Skip to main content
OpenTrials

Clinical trial condition

Demyelinating Diseases

Explore clinical trials studying Demyelinating Diseases. Study availability and eligibility vary by location and protocol.

2,934 public trials 459 recruiting studies
Refine in advanced search Browse all conditions

Demyelinating Diseases trial results

Completed

Exploratory Study to Assess the Effect of Fampridine (BIIB041) on Walking Ability and Balance in Participants With Multiple Sclerosis.

NCT01597297

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Research Site Ath, Belgium
  • Research Site Bruges, Belgium
  • Research Site Brussels, Belgium
  • Research Site Leuven, Belgium
View all 23 locations
View Trial Details
Completed

Efficacy and Safety of GTR in Comparison to Copaxone®

NCT01489254

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Synthon investigational site 112 Irvine, California, United States
  • Synthon investigational site 120 Port Charlotte, Florida, United States
  • Synthon investigational site 130 Sunrise, Florida, United States
  • Synthon investigational site 107 Elk Grove Village, Illinois, United States
View all 133 locations
View Trial Details
Completed

Phase 4 Study of Effect of Aspirin on Flushing in Dimethyl Fumarate-Treated Participants With Relapsing-Remitting Multiple Sclerosis

NCT02090413

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +10 more
Locations
  • Research Site Cork, Ireland
  • Research Site Dublin, Ireland
  • Research Site Dublin, Ireland
  • Research Site Dublin, Ireland
View all 21 locations
View Trial Details
Completed

Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients

NCT01895335

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Investigational Site Number 840077 Birmingham, Alabama, United States
  • Investigational Site Number 840007 Cullman, Alabama, United States
  • Investigational Site Number 840087 Phoenix, Arizona, United States
  • Investigational Site Number 840114 Phoenix, Arizona, United States
View all 169 locations
View Trial Details

Related conditions